{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361699993607633408.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.tem.2009.12.003"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1043276009002124?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1043276009002124?httpAccept=text/plain"}}],"dc:title":[{"@value":"Pituitary somatostatin receptor signaling"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381699993607633409","@type":"Researcher","foaf:name":[{"@value":"Anat Ben-Shlomo"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993607633408","@type":"Researcher","foaf:name":[{"@value":"Shlomo Melmed"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"10432760"}],"prism:publicationName":[{"@value":"Trends in Endocrinology & Metabolism"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2010-03","prism:volume":"21","prism:number":"3","prism:startingPage":"123","prism:endingPage":"133"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S1043276009002124?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S1043276009002124?httpAccept=text/plain"}],"createdAt":"2010-02-10","modifiedAt":"2025-02-18","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360290617722541696","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"DNA damage and growth hormone hypersecretion in pituitary somatotroph adenomas"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567181373770368","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"New potential targets for treatment of Cushing’s disease: epithelial growth factor receptor and cyclin-dependent kinases"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205057624192","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"CONTENTS"},{"@language":"en","@value":"CONTENTS"},{"@value":"The Role of Genetic and Epigenetic Changes in Pituitary Tumorigenesis"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.tem.2009.12.003"},{"@type":"CROSSREF","@value":"10.1172/jci138540_references_DOI_EDli2QB5ZuDNna04GPVXgmf9TAv"},{"@type":"CROSSREF","@value":"10.1007/s11102-015-0637-6_references_DOI_EDli2QB5ZuDNna04GPVXgmf9TAv"},{"@type":"CROSSREF","@value":"10.2176/nmc.ra.2014-0184_references_DOI_EDli2QB5ZuDNna04GPVXgmf9TAv"}]}